Taro’s levetiracetam oral solution is a prescription medication used as an adjunctive therapy in the treatment of partial onset seizures in individuals with epilepsy. This new Taro product is bioequivalent to UCB’s Keppra oral solution, 100mg/ml.
Taro’s levetiracetam oral solution is a prescription medication used as an adjunctive therapy in the treatment of partial onset seizures in individuals with epilepsy. This new Taro product is bioequivalent to UCB’s Keppra oral solution, 100mg/ml.